Jennifer J. Knox
Impact in
- Hepatology top 0.1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Renal cell carcinoma treatment 86
- Oncology 152
- Pancreatic and Hepatic Oncology Research 60
- Cancer Immunotherapy and Biomarkers 37
- Colorectal Cancer Treatments and Studies 27
- Cancer Diagnosis and Treatment 22
- Co-authors
- Eitan Amir (13 shared papers)Mairéad G. McNamara (46 shared papers)Brian I. Rini (47 shared papers)Arnoud J. Templeton (22 shared papers)Ian F. Tannock (19 shared papers)Christian Kollmannsberger (36 shared papers)Toni K. Choueiri (46 shared papers)Francisco Vera-Badillo (16 shared papers)
- Journals
- Journal of Clinical Oncology (168 papers)Annals of Oncology (26 papers)Clinical Genitourinary Cancer (9 papers)Cancer (9 papers)European Journal of Cancer (8 papers)
- Partner nations
- CanadaUnited StatesSouth Korea
In The Last Decade
Jennifer J. Knox
376 papers receiving 17.5k citations
Jennifer J. Knox's Hit Papers
Peers
Comparison fields: 5 of 140
- Hepatology 3.7k
- Oncology 5.5k
- Pulmonary and Respiratory Medicine 6.3k
- Cancer Research 2.4k
- Surgery 3.1k
Countries citing papers authored by Jennifer J. Knox
This map shows the geographic impact of Jennifer J. Knox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer J. Knox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer J. Knox more than expected).
Fields of papers citing papers by Jennifer J. Knox
This network shows the impact of papers produced by Jennifer J. Knox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer J. Knox. The network helps show where Jennifer J. Knox may publish in the future.
Co-authors
The 25 scholars most cited alongside Jennifer J. Knox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 389 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis Hit paper breakdown → | 2014 | 2364 |
| 2 | Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study Hit paper breakdown → | 2009 | 1545 |
| 3 | Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial Hit paper breakdown → | 2019 | 1329 |
| 4 | Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma Hit paper breakdown → | 2013 | 575 |
| 5 | Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis Hit paper breakdown → | 2012 | 489 |
| 6 | Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Hit paper breakdown → | 2008 | 418 |
| 7 | 2008 | 380 | |
| 8 | 2009 | 345 | |
| 9 | 2010 | 345 | |
| 10 | Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium Hit paper breakdown → | 2014 | 313 |
| 11 | The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study Hit paper breakdown → | 2015 | 290 |
| 12 | 2010 | 252 | |
| 13 | 2005 | 243 | |
| 14 | 2017 | 205 | |
| 15 | 2014 | 201 | |
| 16 | 2010 | 194 | |
| 17 | 2013 | 185 | |
| 18 | 2019 | 179 | |
| 19 | 2013 | 172 | |
| 20 | 2014 | 160 |
About Jennifer J. Knox
Jennifer J. Knox is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Hepatology and Surgery, having authored 389 papers that have together received 17.7k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (94 papers), Renal cell carcinoma treatment (86 papers), Cancer Genomics and Diagnostics (74 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (61 papers), Pancreatic and Hepatic Oncology Research (60 papers), Cancer Immunotherapy and Biomarkers (37 papers), Colorectal Cancer Treatments and Studies (27 papers) and Cancer Diagnosis and Treatment (22 papers). The work is most often cited by research in Hepatology (3.7k citations), Oncology (5.5k citations), Pulmonary and Respiratory Medicine (6.3k citations), Cancer Research (2.4k citations) and Surgery (3.1k citations). Jennifer J. Knox has collaborated with scholars based in Canada, United States and South Korea. Frequent co-authors include Eitan Amir, Mairéad G. McNamara, Brian I. Rini, Arnoud J. Templeton, Ian F. Tannock, Christian Kollmannsberger, Toni K. Choueiri, Francisco Vera-Badillo, Boštjan Šeruga and Raya Leibowitz‐Amit. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Genitourinary Cancer, Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.